This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Celgene Corporation. Active years: 2022-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2025
Title: Yuchuan Gong: Innovator in Pharmaceutical Compositions
Introduction
Yuchuan Gong is a notable inventor based in Summit, NJ (US). He has made significant contributions to the field of pharmaceuticals, holding 2 patents that focus on innovative compositions and methods.
Latest Patents
Gong's latest patents include pharmaceutical compositions comprising (S)-2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione. These compositions are designed for oral dosage formulations and include various forms such as enantiomers, mixtures of enantiomers, tautomers, isotopologs, or pharmaceutically acceptable salts, along with a carrier or diluent. The patents also detail methods of preparing and using these pharmaceutical compositions.
Career Highlights
Yuchuan Gong is currently associated with Celgene Corporation, where he continues to advance his research and development efforts in the pharmaceutical industry. His work is pivotal in creating effective treatments that can improve patient outcomes.
Collaborations
Gong collaborates with esteemed colleagues such as Zhengmao Li and Ye Tian, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Yuchuan Gong's contributions to pharmaceutical compositions exemplify the impact of innovative thinking in medicine. His patents and ongoing work at Celgene Corporation highlight the importance of research in developing new therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile